Saffron: the spice that rivals antidepressants in clinical trials
Multiple randomised trials found saffron extract as effective as standard SSRIs for mild-to-moderate depression, with fewer side effects. Here's the evidence.
Saffron is one of the more surprising entries in mood research: a culinary spice with a genuine clinical track record.
What the trials found
Several randomised controlled trials have compared standardised saffron extract to placebo and to standard antidepressants for mild-to-moderate depression. In a number of these, saffron performed comparably to the medication, with a favourable side-effect profile.
How it might work
Saffron's active compounds (crocin and safranal) appear to influence serotonin availability and have antioxidant and anti-inflammatory effects, all plausible routes to a mood benefit.
Read it carefully
The studies are often small and relatively short, and "comparable to an antidepressant" is not the same as "a replacement for one." It's a promising, well-tolerated option to discuss with a clinician, not a reason to stop prescribed treatment.
This article is for general information and is not a substitute for professional care. If you are in crisis or thinking about harming yourself, please contact your local emergency services or a crisis line. See crisis lines.